Serum neurofilament light chain as a preclinical marker of neurodegeneration
Serum neurofilament light chain as a preclinical marker of neurodegeneration
About this item
Full title
Author / Creator
Publisher
London: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
To date, most clinical trials of disease-modifying drugs for neurodegenerative diseases, namely Alzheimer's disease, have been unsuccessful, mainly due to the inclusion of patients with too advanced disease.1 One explanation is that, once the pathophysiological process overcomes the clinical threshold, the excessive neuronal loss could make the the...
Alternative Titles
Full title
Serum neurofilament light chain as a preclinical marker of neurodegeneration
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2313376458
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2313376458
Other Identifiers
ISSN
1474-4422
E-ISSN
1474-4465
DOI
10.1016/S1474-4422(19)30405-3
